title: Nanoengineered strategies for siRNA delivery: from target assessment to cancer therapeutic efficacy.
abstract: The promise of RNA interference (RNAi) technology in cancer therapeutics aims to deliver small interfering RNA (siRNA) for silencing of gene expression in cell type-specific pathway. However, the challenge for the delivery of stable siRNA is hindered by an immune-hostile tumor microenvironment and physiological barriers of the circulatory system. Therefore, the development and validation of safe, stable, and efficient nanoengineered delivery systems are highly essential for effective delivery of siRNA into cancer cells. This review focuses on gene-silencing mechanisms, challenges to siRNA delivery, design and delivery of nanocarrier systems, ongoing clinical trials, and translational prospects for siRNA-mediated cancer therapeutics.
authors.affiliation: IPS Academy, College of Pharmacy, A. B. Road, Indore, MP, 452 012, India. dineshdops@gmail.com.
authors.forename: Dinesh Kumar
authors.initials: DK
authors.lastname: Mishra
authors.affiliation: IPS Academy, College of Pharmacy, A. B. Road, Indore, MP, 452 012, India.
authors.forename: Neelam
authors.initials: N
authors.lastname: Balekar
authors.affiliation: Department of Molecular Biology, National Institute for Research in Environmental Health, Indian Council of Medical Research (ICMR), Bhopal, India.
authors.forename: Pradyumna Kumar
authors.initials: PK
authors.lastname: Mishra
mesh_terms: D020868:Gene Silencing; D006801:Humans; D036103:Nanotechnology; D009369:Neoplasms / Q000628:therapy; D034741:RNA, Small Interfering / Q000008:administration & dosage*; D016896:Treatment Outcome
chemical_list: D034741:RNA, Small Interfering
keywords: Drug delivery; Nanomedicine; Oncotherapy; RNA interference; Translational research